Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Inflammatory Breast Neoplasms × olaparib × Clear all

Sponsor

Conditions

Ovarian Neoplasms 19 Breast Neoplasms 10 Prostatic Neoplasms 9 Triple Negative Breast Neoplasms 7 Fallopian Tube Neoplasms 7 Neoplasm Metastasis 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Fanconi Anemia, Complementation Group D1 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Endometrial Neoplasms 2 Castration-Resistant Prostate Carcinoma 2 Carcinoma 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Prostate 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Peritoneal Neoplasms 1

Interventions

Cyclophosphamide 11 Doxorubicin 7 Trastuzumab 6 Paclitaxel 6 Taxes 5 Radiotherapy 4 Epirubicin 4 Docetaxel 4 Carboplatin 4 Albumin-Bound Paclitaxel 4 pembrolizumab 3 Melphalan 3 pertuzumab 2 eribulin 2 Thiotepa 2 Tamoxifen 2 Peripheral Blood Stem Cell Transplantation 2 Lapatinib 2 Fluorouracil 2 Filgrastim 2 130-nm albumin-bound paclitaxel 2 trastuzumab biosimilar HLX02 1 talimogene laherparepvec 1 sargramostim 1 ruxolitinib 1 romidepsin 1 pazopanib 1 nintedanib 1 neratinib 1 grapiprant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡